Black Rock Inc. Renovo Rx, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,162 shares of RNXT stock, worth $12,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,162
Previous 20,840
56.04%
Holding current value
$12,368
Previous $27,000
62.96%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RNXT
# of Institutions
29Shares Held
11MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$4.68 Million1.85% of portfolio
-
Awm Investment Company, Inc. New York, NY2.29MShares$3.08 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.82 Million0.0% of portfolio
-
Bank Of The West975KShares$1.32 Million0.27% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL689KShares$929,5780.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $12.2M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...